Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes

J Virol. 1996 Sep;70(9):5799-806. doi: 10.1128/JVI.70.9.5799-5806.1996.

Abstract

Numerous studies of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes (CTL) have examined their ability to recognize B-cell lines expressing recombinant HIV-1 proteins, but relatively few data regarding the lysis of HIV-1-infected cells by CTL are available. We studied the ability of HIV-1-specific CTL clones of defined epitope specificity and HLA restriction to lyse infected CD4+ cells at serial time points following infection. CD4+ cell lines were acutely infected with HIV-1 IIIB at a high multiplicity of infection, and the kinetics of cell lysis were examined and compared with the kinetics of viral replication. Intracellular HIV-1 p24 expression was detected by 1 to 2 days after infection, reaching over 98% positive cells by day 4. Recognition of the infected cells by HLA A2- and B14-restricted CTL clones closely paralleled intracellular p24 expression and preceded peak virion production. The maximal levels of lysis with Gag-, reverse transcriptase-, and envelope-specific clones were different, however. The Gag- and envelope-specific clones lysed infected cells at levels equivalent to peptide-sensitized controls, whereas lysis by the reverse transcriptase-specific clones plateaued at a lower level. Peptide titration curves indicated that this effect was not due to differences in sensitivity to the cognate epitopes for the different clones. Although HIV-1 infection induced an approximately 50% decrease in class I HLA expression on the surface of infected cells, lysis by CTL clones was unaffected. These studies indicate that HIV-1-specific CTL can efficiently lyse HIV-1-infected CD4+ cells and suggest that the partial downregulation of class I molecules in infected cells does not significantly affect recognition by CTL.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / immunology*
  • Amino Acid Sequence
  • Antibodies
  • B-Lymphocytes / immunology
  • B-Lymphocytes / virology
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Line
  • Clone Cells
  • Cytotoxicity, Immunologic*
  • Epitopes
  • Flow Cytometry
  • Gene Products, gag / chemistry
  • Gene Products, gag / immunology
  • HIV Core Protein p24 / biosynthesis
  • HIV Core Protein p24 / immunology
  • HIV-1 / immunology*
  • HIV-1 / physiology
  • HLA-A2 Antigen / immunology
  • HLA-B Antigens / immunology
  • HLA-B14 Antigen
  • Humans
  • Molecular Sequence Data
  • Oligopeptides / chemical synthesis
  • Oligopeptides / immunology
  • T-Lymphocytes, Cytotoxic / immunology*
  • Tumor Cells, Cultured
  • Virus Replication

Substances

  • Antibodies
  • Epitopes
  • Gene Products, gag
  • HIV Core Protein p24
  • HLA-A2 Antigen
  • HLA-B Antigens
  • HLA-B14 Antigen
  • Oligopeptides